Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-04-19 00:00:00 ET · period of report 2022-04-18 · accession 0001104659-22-047468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-19 | 2022-04-18 | PTGX | Ali Asif | CFO | A - Grant | $0.00 | +13.8K | 13.8K | New | $0 |
| D | 2022-04-19 | 2022-04-18 | PTGX | Ali Asif | CFO | A - Grant | $0.00 | +82.5K | 82.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | A | A | 13,750 | $0.00 | 13,750 | D | — | — | (F1) Represents grant of restricted stock units payable solely in shares of the Issuer's common stock that will vest in four annual installments on April 18, 2023, 2024, 2025 and 2026, subject to the Reporting Person's continued service to the Issuer. |
| 2 | Derivative | Stock Option (right to buy) | 2022-04-18 | A | A | 82,500 | $0.00 | 82,500 | D | $19.19 · — to 2032-04-18 | 82,500 Common Stock | (F2) The stock option represents a right to purchase a total of 82,500 shares of the Issuer's common stock, one quarter of which will vest on April 18, 2023, with the remaining three quarters vesting in equal monthly installments through April 18, 2026, subject to the Reporting Person's continued service to the Issuer. |